(Q37252097)

19 August 2017

Triple-negative and non-triple-negative invasive breast cancer: association between MR and fluorine 18 fluorodeoxyglucose PET imaging (English)

1 reference

19 August 2017

Marjan S Bolouri

1

1 reference

19 August 2017

Sjoerd G Elias

2

1 reference

19 August 2017

Dorota J Wisner

3

1 reference

19 August 2017

Spencer C Behr

4

1 reference

19 August 2017

Randall A Hawkins

5

1 reference

19 August 2017

Sachiko A Suzuki

6

1 reference

19 August 2017

Krysta S Banfield

7

1 reference

19 August 2017

Bonnie N Joe

8

1 reference

19 August 2017

Nola M Hylton

9

1 reference

19 August 2017

language of work or name

English

0 references

publication date

22 July 2013

1 reference

19 August 2017

1 reference

19 August 2017

269

1 reference

19 August 2017

2

1 reference

19 August 2017

354-361

1 reference

Triple receptor-negative breast cancer: imaging and clinical characteristics

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807081

Triple-Negative Breast Cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807081

Triple-negative breast cancer: present challenges and new perspectives

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807081

Triple-negative breast cancer: correlation between MR imaging and pathologic findings

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807081

Invasive breast cancer: predicting disease recurrence by using high-spatial-resolution signal enhancement ratio imaging

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807081

Triple-negative breast cancer: clinical features and patterns of recurrence

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807081

Partial-volume correction in PET: validation of an iterative postreconstruction method with phantom and patient data

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807081

Vascularity assessment of breast lesions with gadolinium-enhanced MR imaging.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807081

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807081

Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807081

Triple-negative breast cancer: early assessment with 18F-FDG PET/CT during neoadjuvant chemotherapy identifies patients who are unlikely to achieve a pathologic complete response and are at a high risk of early relapse.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807081

¹⁸F-FDG PET and biomarkers for tumour angiogenesis in early breast cancer.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807081

Triple-negative breast cancer: correlation between imaging and pathological findings

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807081

Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807081

The relationship between vascular and metabolic characteristics of primary breast tumours

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807081

Comparison of FDG-PET and dynamic contrast-enhanced MRI in the evaluation of suggestive breast lesions

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807081

Contrast-Enhanced Magnetic Resonance Imaging to Assess Tumor Histopathology and Angiogenesis in Breast Carcinoma

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807081

Pathophysiologic basis of contrast enhancement in breast tumors

3 September 2018

1 reference

PubMed

12 December 2020

Dynamic contrast-enhanced MRI of primary rectal cancer: quantitative correlation with positron emission tomography/computed tomography

1 reference

PubMed

12 December 2020

1 reference

12 December 2020

Multimodality imaging of triple receptor-negative tumors with mammography, ultrasound, and MRI

1 reference

PubMed

12 December 2020

Identifiers

DOI

10.1148/RADIOL.13130058

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

23878283

1 reference